Spotlight on anifrolumab and its potential for the treatment of moderate-to-severe systemic lupus erythematosus: evidence to date

Previous reports have described the appearance of systemic lupus erythematosus (SLE) cases following interferon-α (IFN-α) therapy, IFN-regulated gene expression is significantly increased in SLE, and an association between SLE and gene variants belonging to IFN downstream pathways has been shown. Ba...

Descripción completa

Detalles Bibliográficos
Autores principales: Felten, Renaud, Scher, Florence, Sagez, Flora, Chasset, François, Arnaud, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514126/
https://www.ncbi.nlm.nih.gov/pubmed/31190735
http://dx.doi.org/10.2147/DDDT.S170969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514126/
https://www.ncbi.nlm.nih.gov/pubmed/31190735
http://dx.doi.org/10.2147/DDDT.S170969

Ejemplares similares